MERIT 2022 DIA Applied Clinical Trials Interview

Imaging is an integral part of many clinical studies, particularly in the fields of oncology and ophthalmology. Learn why imaging and centralized review are essential for clinical trials and how to address challenges in these studies. Yijun Huang, MERIT's CEO, also gives an overview of MERIT's technology platform and what it offers to partners, as well as advantages to MERIT partnerships for imaging clinical trials.